Fig. 7. RanBP1 retains its centrosomal localization after exposure to either
nocodazole (a) or Taxol (b). Endogenous RanBP1 (second column) and
-tubulin (third column) were revealed with FITC- and
rhodamine-conjugated secondary antibodies, respectively. DNA was
counterstained with DAPI (first column on the left). The rightmost column
shows the merged signals of RanBP1,
-tubulin and DAPI staining. Scale
bar, 10 µm.